FDA Blows Zyprexa Whistle
Eli Lilly currently is being sued by attorney generals in seven states for fraud because of the way in which they market their drug Zyprexa. Zyprexa is FDA approved for the treatment of schizophrenia and bipolar disorder, but can increase a patient's risk for diabetes and severe weight gain drastically.
It recently has come out that Eli Lilly encouraged their drug representatives to promote Zyprexa for non-FDA approved, "off-label," uses. Other antipsychotic medications also are currently being reviewed to determine if they also cause excessive weight gain.
Related Links:
Legal View: Zyprexa
FDA Staffer Urges Scrutiny of Lilly Drug
State Has Sued Lilly over Drug
Lilly's Zyprexa Still in Courtroom
More Questions Based on Eli Lilly Zyprexa Documents